India Presses Chinese API Firms Over Quality Concerns

 
• By Ying Huang and Anju Ghangurde
Pills
CHINESE API FIRMS ARE UNDER SCRUTINY BY THE INDIAN REGULATOR

More from Drug Safety

More from Pink Sheet